News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Supriya Peshin: Bosutinib-induced pleural effusion – class effect and cross-intolerance to all TKIs
Supriya Peshin/X
Feb 3, 2025, 13:12

Supriya Peshin: Bosutinib-induced pleural effusion – class effect and cross-intolerance to all TKIs

Supriya Peshin, Internal Medicine Resident at Ballad Health, shared a post on X about a recent paper she co-authored with colleagues published in Hematology Reports:

“New publication.

Congratulations team. Let’s continue working hard.

Our case highlights the class effect and cross intolerance of all TKIs in an elderly female with Ph+ ALL and Ponatinib might be a suitable option for these cases.”

“Bosutinib-Induced Pleural Effusion – Class Effect and Cross-Intolerance to All Tyrosine Kinase Inhibitors”

Authors: Nikhil Vojjala, Hizqueel Sami, Nikhil Kotla, Supriya Peshin, Kanika Goyal, Soumya Kondaveety, Rishab Prabhu, Geetha Krishnamoorthy.

Supriya Peshin: Bosutinib-induced pleural effusion - class effect and cross-intolerance to all TKIs

More posts featuring Supriya Peshin.

cancer Geetha Krishnamoorthy Hizqueel Sami Kanika Goyal Nikhil Kotla Nikhil Vojjala OncoDaily Oncology Rishab Prabhu Soumya Kondaveety Supriya Peshin TKIs
Special Coverage
Insight
Feb 3, 2025, 13:12
Supriya Peshin: Bosutinib-induced pleural effusion - class effect and cross-intolerance to all TKIs
Opinion
Feb 3, 2025, 13:10
Gustavo Viani: Does acute toxicity predict late toxicity in prostate radiotherapy?
Blog
Feb 3, 2025, 13:06
Stephen V Liu: Grateful for the chance to learn from the top lung cancer experts at ITCD2025
Blog
Feb 3, 2025, 12:59
Hot Topic: Data Table 2 - Association of Cancer Center Administrators
Societies
Feb 3, 2025, 12:57
Keeping up with WLC25 by Estela Rodriguez
Science
Feb 3, 2025, 12:47
Myeloma Paper of the Day, February 3rd, suggested by Robert Orlowski
Blog
Feb 3, 2025, 12:46
Patrick Hwu: Identifying neoantigens from metastatic tumors
Blog
Feb 3, 2025, 12:02
A new month brings new opportunities to make an impact - Medicaid Cancer Foundation
Science
Feb 3, 2025, 11:59
James Crowley: The identification of tumor-specific targets in expanding immunotherapy development
Blog
Feb 3, 2025, 11:43
Susan Furth: Pleasured to join Women to Watch Media with Sue Rocco for episode 2
Blog
Feb 3, 2025, 11:42
Jarushka Naidoo: A showcase of the research work of our oncology trainees across Ireland
Blog
Feb 3, 2025, 11:36
Working together to achieve better outcomes for everyone affected by ovarian cancer - OCRF